A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma
Clinical trial NCT05022927 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05022927
- Sponsor
- Chugai Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2025-12-31
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.